# Guangzhou Huayin Medical Laboratory Center

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangzhou-huayin-medical-laboratory-center

- Industry: Healthcare
- Headquarters: Guangzhou, China
- Website: www.huayinlab.com
- Total disclosed funding: $102M
- Latest round: Series C (Apr 8, 2020)
- Investors on record: 8

## About

Founded in 2015 and based in Guangzhou, China, Guangzhou Huayin Medical Laboratory Center operates as a medical company that focuses on providing comprehensive medical services. It was recognized as the National High-tech Enterprise. Chunbo Huang, the company's founder, graduated from South China University of Technology and is also the founder of Wondfo Biologics. The company has 18 branch offices in Beijing, Wuhan, Changsha, and other cities. In 2012, it jointly established the Huayin Pathology Diagnostic Center with Southern Medical University. In December 2020, Guangzhou Huayin Medical Laboratory Center raised a pre-IPO funding for CNY 100 million.

The company is mainly engaged in medical testing and diagnosis technology services. It has technical platforms such as drug clinical trial centers, public health testing centers, and forensic identification centers. It provides pathological diagnosis, medical testing, genetic testing, health management, public health testing, and other services. The company mainly served clients in clinical testing, pathological diagnosis, public health, forensic identification, and other fields.

The company generates revenue by providing testing and diagnosis technology services.

## Funding rounds

- Series C, Apr 8, 2020, $85M — Bank of China Group Investment, Chongqing Venture Capital, GL Capital Group, Everest VC, In Capital, Qianhai Ark Capital
- Series B, May 1, 2017 — GTJA Investment Group
- Series A, Jan 1, 2013, $17M — Sino Asia Capital

## Investors

- Sino Asia Capital (https://capitalatlas.ai/funds/sino-asia-capital) — Series A
- GTJA Investment Group (https://capitalatlas.ai/funds/gtja-investment-group) — Series B
- Bank of China Group Investment — Series C
- Chongqing Venture Capital (https://capitalatlas.ai/funds/chongqing-venture-capital) — Series C
- GL Capital Group (https://capitalatlas.ai/funds/gl-capital-group) — Series C
- Everest VC (https://capitalatlas.ai/funds/everest-vc) — Series C
- In Capital — Series C
- Qianhai Ark Capital (https://capitalatlas.ai/funds/qianhai-ark-capital) — Series C